NCT06501469Active, not recruiting
Biomarkers in Parkinsonian Syndromes
Prospective, Observational Study to Identify Biomarkers in Parkinsonian Syndromes
Source: ClinicalTrials.gov · Last updated 17 Jun 2026
Brief summary (registry, in English)
This is a prospective observational study to identify biomarkers in parkinson syndromes. Patients with parkinsonian syndromes at the early stages of disease will be recruited and will be followed up until their established clinical diagnosis or for at least 5 years. In this population, imaging and wet biomarkers as well as clinical data will b systematically collected.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 20 Jun 2024
- Start date
- 23 Mar 2022
- Primary completion date
- 13 May 2031
- Lead sponsor
- Non-profit organization for scientific research in Parkinson's disease and related disorders
- Diseases
- Parkinson disease
- NCT number
- NCT06501469
What you commit to
- Study type: Observational
- Planned participants: 200
- From 23 Mar 2022 to the primary completion date, 13 May 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Drug-induced parkinsonism (eg, neuroleptics, lithium, valproic acid, metoclopramide).
Other illness
- Metabolic conditions related parkinsonism (eg, Wilson's disease, hypoparathyroidism).
Age
- Other serious diseases that indicate a life expectancy of \<5 years.
Other
- Structural lesions on brain magnetic resonance imaging (MRI) that explain the symptoms, such as normal pressure hydrocephalus, moderate to severe chronic vascular encephalopathy, cerebral infarction, neoplasm
- Active participation in other interventional clinical studies
Criteria the registry did not label
- IΙnclusion Criteria:
- Written informed consent, including consent to monitoring
- Patients with Parkinsonism and disease duration \< 2 years
- Patients with Parkinsonism and disease duration \> 2 years
- Healthy individuals without any neurological disease
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HYGEIA Hospital, Parkinson's disease and Movement Disorders Department Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.